Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Current Features

Advertisement

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
Current Features

Preparing for Change: A Look- Forward at the New UK Clinical Trial Regulations with Olive McCormick, Almac Group

On 28th April, the most significant overhaul of the UK’s clinical trial regulations in two decades will take full effect. These operational reforms aim to stream...
Continue Reading →
Current Features

FDA Unannounced Inspections and the Standard of Continuous Readiness: Insights from Patrick Nieuwenhuizen

This industry article is from Pharma Conversations Podcast, hosted by Shada Warreth and Elizabeth Hunt. This article was authored by Patrick Nieuwenhuizen, M...
Continue Reading →
Current Features

Training & Education Within Drug Discovery & Development Industry

The drug discovery and development industry demands scientific rigour, strict regulation, and interdisciplinary expertise. This field unites molecular biology, c...
Continue Reading →
Current Features

Advancing Life Sciences with Automation: The Key to Faster, Safer and More Sustainable Drug Delivery

In the race to deliver life-saving therapies, the life sciences industry continually confronts unprecedented complexity and urgency. The challenge is clear: pati...
Continue Reading →
Current Features

Project Management and Process Improvements for CDMOs

The Strategic Role of Project Management in CDMOs Contract Development and Manufacturing Organisations (CDMOs) operate in a highly competitive landscape where...
Continue Reading →
Current Features

Optimising Viral Vector Manufacturing by Building Scalable Platforms from Early Research to GMP Production

Cell and gene therapies (CGTs) are redefining what is possible in modern medicine, offering innovative and potentially curative treatments for diseases that were...
Continue Reading →
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025

Company Profiles